Jean-Paul Benhamou

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐕𝐢𝐬𝐮𝐚𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧: 𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐲 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 Download PDF Brochure: https://lnkd.in/d6fR8vc3 Exciting developments in the endoscopy equipment sector! The market is experiencing remarkable growth, projected to expand from $32.3B (2024) to $46.2B by 2029, with a robust CAGR of 7.4%. Here's what's driving this transformation: Innovation Across the Spectrum: 🔹 Flexible Endoscopes: Leading the charge with enhanced maneuverability and patient comfort, perfect for complex GI procedures 🔹 Disposable Solutions: Addressing infection control concerns and reducing reprocessing costs while ensuring optimal safety 🔹 Rigid Endoscopes: Maintaining their crucial role in specific procedures where precise visualization is paramount 🔹 Capsule Endoscopy: Revolutionary tech providing non-invasive alternatives for diagnostic procedures 🔹 Robot-assisted Systems: The cutting edge of precision medicine, combining AI with surgical expertise What's driving this growth? An aging population, rising GI disorders, and increasing demand for minimally invasive procedures. Healthcare facilities worldwide are investing in advanced endoscopic technologies to improve patient outcomes and operational efficiency. ✨ The future of endoscopy is not just about visualization – it's about precision, safety, and improved patient experiences. As healthcare continues to evolve, these innovations will play a crucial role in shaping the future of medical diagnostics and treatment. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Olympus Corporation, KARL STORZ, Boston Scientific, Johnson & Johnson, Stryker, Medtronic, FUJIFILM Holdings Corporation, Hoya, Nipro Corporation - Global, Smith+Nephew, Intuitive Other Companies that are Operating in this Market Globally: Fujifilm Healthcare UK Scitech Medical Creo Medical NextPhase Medical Devices Santax Medico - Danmark Tekno Surgical NP Medical Inc. TSC Life Vision Medical Pusen Medical LifeMed Group Ambu Ltd. - United Kingdom & Ireland   TBS INDIA TELEMATIC AND BIOMEDICAL SERVICES Avensys UK Ltd SCHÖLLY FIBEROPTIC GMBH MICRO-TECH Europe GmbH Tecmed Pty Ltd Shalya Duomed Group Ecolab Healthcare ANZ Gemco Medical Solutions Diversatek Healthcare Henke-Sass, Wolf TAG Medical Products Corporation Ltd.    Obex Medical Medtechnica PMT Corporation LAS Electromedicina #HealthcareTechnology #MedicalDevices #Endoscopy #HealthcareInnovation #MedicalInnovation #HealthTech

1

On World Patient Safety Day, Temos International reaffirms our commitment to enhancing patient safety worldwide. This year's theme, "Improving Diagnosis for Patient Safety," emphasizes the importance of accurate diagnosis in preventing errors and ensuring optimal treatment outcomes. At Temos, we recognize that this involves minimizing risks through safe practices, making accurate diagnoses, clear communication, and robust systems that support healthcare providers in delivering the best care. Temos accreditation programs focus on creating systems that enhance diagnostic safety and drive data-driven decisions that strengthen healthcare facilities clinically and operationally. Collaborating with Temos empowers healthcare leaders to address issues like malpractice and medical errors by improving communication and documentation, fostering a more cohesive medical staff for better clinical outcomes. With the guidance from Temos, healthcare leaders can enhance analytic processes and utilize data insights to drive positive change and refine patient care approaches, which ultimately reduces diagnostic errors and elevates patient safety. So on this World Patient Safety Day, let's collectively advocate for the critical role accreditation plays in achieving safer healthcare. Join us in prioritizing patient safety by partnering with Temos to elevate your healthcare facility's standards and make a meaningful impact on patient care. 🔗 www.temos-worldwide.com 📧 info@temos-international.com #WorldPatientSafetyDay #ImprovingDiagnosis #PatientSafety #Temos #accreditation #healthcare #german #clinics #medical #expert #healthcareindustry #patientcare #patientexperience #riskmanagement #patientsafety #FAQ #healthandsafety #vision #mission #patientcentricity #reliability #ceo #benefits #careerdevelopment #network #german #worldpatientsafetyday #worldhealthorganization #patientadvocacy #WHO #UnitedNations

22

‏2‏ ‏תגובות‏

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 Prophecy Market Insights 𝐄𝐧𝐞𝐫𝐠𝐲-𝐁𝐚𝐬𝐞𝐝 𝐚𝐞𝐬𝐭𝐡𝐞𝐭𝐢𝐜 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟕.𝟐𝟖 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟐𝟓.𝟏𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟒.𝟔%. Energy-based aesthetic devices represent state-of-the-art medical technology utilized in various aesthetic and dermatological procedures for appearance enhancement and treatment of multiple cutaneous conditions. These deliver different forms of energy, such as light, heat, radiofrequency, or ultrasound, to selectively affect the designated structures within the skin and deeper tissues. They act by stimulating collagen production, cellular regeneration, and controlled damage that leads to body healing processes. Laser systems, intense pulsed light (IPL) devices, radiofrequency machines, and ultrasound devices are more common types. 𝙁𝙤𝙧 𝙈𝙤𝙧𝙚 𝙄𝙣𝙛𝙤 𝙑𝙞𝙨𝙞𝙩: https://lnkd.in/dVjbdEDi Key Players Includes: Candela Medical APAC | Merz Pharma GmbH & Co KGaA Reinheim | Lumenis | Alma Lasers | ZELTIQ | El.En. S.p.A. | Cutera, Inc. | Sisram Medical | Allergan | Cynosure, LLC.

3

Israel’s first implantation of an innovative defibrillator at Hillel Yaffe Medical Center. The cardiac arrhythmia unit at Hillel Yaffe Medical Center implanted a new generation defibrillator (Crome™), enabling remote monitoring through a dedicated app directly to the patients’ mobile phone by utilizing BlueSync technology. The device implantation was successfully performed by Dr. Mark Kazatzker, director of the pacemaker service, and Dr. Gilad Margolis, a senior physician in the arrhythmia unit, on a patient with life-threatening ventricular arrhythmias. "Beyond the fact that the new device has longer battery longevity compared to other devices used in Israel, the patient can monitor his own condition in real time through a dedicated app, being aware of the slightest events and even alerting medical officials of the diagnosed changes. If the defibrillator goes into operation, the patient can show emergency medicine professionals in the field or in the ER data through the app, which in the past could only be ascertained in the hospital by cardiology staff members using a dedicated programmer. This is another important step in personalized and patient accessible medicine," notes Dr. Eran Leshem, director of the arrhythmia and pacemaker unit at Hillel Yaffe Medical Center. #defibrillator #cardiology #medicaldevice Medtronic Eran Leshem - Rubinow

39

𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝗻𝗱𝗼𝘀𝗰𝗼𝗽𝗶𝗰 𝘀𝗶𝗻𝘂𝘀 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝗶𝘇𝗲 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗿𝗲𝗮𝗰𝗵 𝗨𝗦𝗗 𝟮,𝟯𝟯𝟴.𝟴𝟭 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟮,𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗻𝗴 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟳.𝟴% 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dYBTkphy The functional endoscopic sinus surgery (fess) market refers to the industry providing equipment and solutions for minimally invasive sinus surgery. FESS is used to treat chronic sinusitis and other nasal conditions by improving sinus drainage and airflow. The functional endoscopic sinus surgery (FESS) market is experiencing robust growth due to increasing prevalence of chronic sinusitis, advancements in minimally invasive surgical techniques, and rising awareness about effective treatment options. #functionalsinusendoscopy #endoscopicsurgery #sinussurgery #fessmarket #entmedicine #medicaldevices #sinustreatment #healthcareinnovation #endoscopicsolutions #enthealthcare

9

𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝗻𝗱𝗼𝘀𝗰𝗼𝗽𝗶𝗰 𝘀𝗶𝗻𝘂𝘀 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝗶𝘇𝗲 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗿𝗲𝗮𝗰𝗵 𝗨𝗦𝗗 𝟮,𝟯𝟯𝟴.𝟴𝟭 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟮, 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗻𝗴 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟳.𝟴% 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dYBTkphy The functional endoscopic sinus surgery (fess) market refers to the industry providing equipment and solutions for minimally invasive sinus surgery. FESS is used to treat chronic sinusitis and other nasal conditions by improving sinus drainage and airflow. The functional endoscopic sinus surgery (FESS) market is experiencing robust growth due to increasing prevalence of chronic sinusitis, advancements in minimally invasive surgical techniques, and rising awareness about effective treatment options. In addition, growing prevalence of sinus-related disorders and the rising demand for outpatient procedures that reduce recovery time are among the key factors driving the market growth. #functionalendoscopicsinussurgery #fessmarket #sinussurgery #entcare #endoscopicsurgery #minimallyinvasivesurgery #healthcaremarket #otolaryngology #sinushealth #medicaldevices

2

𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝗻𝗱𝗼𝘀𝗰𝗼𝗽𝗶𝗰 𝘀𝗶𝗻𝘂𝘀 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝗶𝘇𝗲 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗿𝗲𝗮𝗰𝗵 𝗨𝗦𝗗 𝟮,𝟯𝟯𝟴.𝟴𝟭 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟮,𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗻𝗴 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟳.𝟴% 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dYBTkphy The functional endoscopic sinus surgery (fess) market refers to the industry providing equipment and solutions for minimally invasive sinus surgery. FESS is used to treat chronic sinusitis and other nasal conditions by improving sinus drainage and airflow. The functional endoscopic sinus surgery (FESS) market is experiencing robust growth due to increasing prevalence of chronic sinusitis, advancements in minimally invasive surgical techniques, and rising awareness about effective treatment options. #functionalendoscopicsinussurgery #fessmarket #sinussurgery #entcare #endoscopicsurgery #minimallyinvasivesurgery #healthcaremarket #otolaryngology #sinushealth #medicaldevices

3

The global #hemostats #market, valued at $𝟐.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑, is set for substantial growth, projected to reach $𝟒.𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟕% (𝟐𝟎𝟐𝟒–𝟐𝟎𝟑𝟐). This rapid expansion is driven by rising surgical procedures, increased demand for effective blood loss management, and advances in healthcare infrastructure #worldwide. As innovations in hemostatic technology continue, companies and healthcare providers are poised to benefit from this #dynamic market. 𝐓𝐡𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:- https://lnkd.in/gfMsJeWb 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 B. Braun Melsungen Aktiengesellschaft | Baxter International Inc. | BD | GELITA MEDICAL GmbH | Integra LifeSciences. | Johnson & Johnson | Medtronic | PFIZER INC. | Stryker. | Teleflex. | Other Prominent Players #HealthcareInnovation #SurgicalSolutions #HemostatsMarket #MedicalDevices #GlobalMarketGrowth #Healthcare

11

𝗖𝗼𝗹𝗹𝗮𝗴𝗲𝗻 𝗪𝗼𝘂𝗻𝗱 𝗖𝗮𝗿𝗲 𝗗𝗿𝗲𝘀𝘀𝗶𝗻𝗴𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 *𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗥𝗲𝗽𝗼𝗿𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dpRvhW3R The rising incidence of chronic wounds, coupled with an increasing geriatric population and advancements in wound care technologies, are significant factors driving the growth of the collagen wound care dressings market. One of the major growth drivers is the increasing prevalence of chronic diseases such as diabetes and vascular conditions, which often lead to chronic wounds like diabetic foot ulcers and pressure ulcers. The aging population, which is at a higher risk for such chronic wounds, further boosts the demand for collagen-based dressings. These dressings provide an optimal environment for wound healing by promoting cell migration and growth, making them an essential solution for managing chronic wounds. *𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝘆𝗽𝗲: Collagen Sheets, Collagen Particles, Collagen Gels, Collagen Pads, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Chronic Wounds, Acute Wounds, Surgical Wounds, Others *𝗕𝘆 𝗘𝗻𝗱-𝗨𝘀𝗲𝗿: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Smith+Nephew, Integra LifeSciences, 3M, Coloplast, Organogenesis, Medline Industries, LP, Convatec, Derma Sciences, Hollister Incorporated, Mölnlycke Health Care, Johnson & Johnson, BSN medical, Human BioSciences, Inc. USA, Collagen Solutions, Acelity, Alliqua BioMedical, Inc., AMERX Health Care Corporation, Kerecis #CollagenWoundCare #WoundHealing #ChronicWounds #DiabeticFootUlcers #PressureUlcers #WoundCareProducts #AdvancedWoundCare #WoundHealingTechnologies #CellMigration #GeriatricPopulation #ChronicDiseases #VascularDiseases #Diabetes #WoundManagement #SkinHealing #Healthcare #WoundDressings #WoundCareSolutions #MedicalSupplies #WoundCareInnovation

1

𝗦𝗽𝗶𝗻𝗲 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙 𝗼𝗿 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻: https://lnkd.in/dmeQfKZv The report provides a comprehensive overview of the Spine Biologics industry, detailing the development of its supply chain and the current market status for Anterior Cervical Discectomy and Fusion (including Bone Graft and Bone Graft Substitute) and Posterior Lumbar Interbody Fusion (also featuring Bone Graft and Bone Graft Substitute). It highlights key enterprises in both developed and developing markets while analyzing cutting-edge technologies, patents, popular applications, and market trends. Regionally, the report indicates steady growth in North America and Europe, fueled by government initiatives and rising consumer awareness, while Asia-Pacific—especially China—dominates the global Spine Biologics market due to strong domestic demand, favorable policies, and a robust manufacturing base. Additionally, the report delves into market dynamics, trends, challenges, and opportunities, offering a holistic understanding of the Spine Biologics landscape and insights into individual components and stakeholders. *𝗕𝘆 𝗧𝘆𝗽𝗲: Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), BMAC (Bone Marrow Aspirate Concentrate) *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Medtronic, DePuy Synthes, Stryker, NuVasive, Zimmer Biomet, Orthofix, Globus Medical, Alphatec Spine, K2M, Exactech, Wright Medical, X-spine Systems, Inc., Arthrex #SpineBiologics #BoneGraft #BoneGraftSubstitute #SpinalSurgery #AnteriorCervicalDiscectomy #PosteriorLumbarInterbodyFusion #RegenerativeMedicine #SpineHealth #OrthopedicInnovation #SpinalFusion #Biomechanics #MedicalDevices #HealthcareTechnology #PatientOutcomes #SurgicalTrends #ClinicalResearch #MarketTrends #AsiaPacificMarket #NorthAmericaSpine #EuropeSpineIndustry    

1

Day in the Life of a Medical Sales Manager - Deal in Greece Part 2 #medicaldevicesales #medicaldevices #medicaldevice #medicalsales #medicalsalescollege #sales #success #newtomedicaldevicesales #medicine #medtech

2

📊 𝐅𝐥𝐞𝐱𝐢𝐛𝐥𝐞 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐕𝐢𝐝𝐞𝐨 𝐂𝐲𝐬𝐭𝐨𝐬𝐜𝐨𝐩𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐔𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 🚑 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gTWuZv88 The flexible digital video cystoscope market is witnessing significant growth, driven by advancements in endoscopic technologies, increasing demand for minimally invasive diagnostic procedures, and the rising prevalence of urological conditions such as bladder cancer and urinary tract infections (UTIs). A flexible digital video cystoscope is a specialized endoscopic device used for examining the interior of the bladder and urethra. Unlike traditional rigid cystoscopes, flexible digital video cystoscopes offer greater patient comfort, easier maneuverability, and improved visualization through high-definition video capabilities. These benefits make them increasingly popular in clinical settings for both diagnostic and therapeutic procedures, fueling market expansion. One of the primary drivers of the flexible digital video cystoscope market is the growing incidence of urological disorders, particularly bladder cancer, which requires routine cystoscopic examination for diagnosis, monitoring, and treatment. According to the World Cancer Research Fund, bladder cancer is one of the most common cancers worldwide, particularly in aging populations. Flexible cystoscopy is a key tool in early diagnosis and surveillance of bladder cancer, allowing for the detection of tumors and other abnormalities with minimal discomfort for patients. As the global burden of urological conditions increases, the demand for flexible digital video cystoscopes is expected to rise. #Company KARL STORZ Olympus Corporation Stryker Richard Wolf Hoya SCHOELLY-USA.com Tiansong Medical Instrument KEBOMED UK #Type • Hematuria • Urinary Tract Stones • Postoperative Follow-up of Bladder Cancer • Others #Application • Hospitals • Ambulatory Surgical Centers • Others #Cystoscopy #DigitalCystoscope #Urology #MinimallyInvasive #HealthcareInnovation #MedicalDevices

1

Pressure ulcers, also known as bedsores, are a significant concern in long-term care settings, particularly affecting patients with limited mobility. VENDAJE's innovative DHAM allograft introduces a pivotal advancement in the support for treatment and management of these challenging wounds. What makes VENDAJE® particularly suited for pressure ulcer treatment is its ability to provide a protective barrier over the wound environment. The natural properties of the amniotic tissue, preserved through the BioRetain process, facilitate a protective environment, actively reducing inflammation and promoting rapid and effective healing. Implementing VENDAJE into the care regimen for patients at risk of or suffering from pressure ulcers can improve patient outcomes, therefore reducing treatment durations, and enhancing patient comfort and quality of life. Healthcare providers across the spectrum—from hospitals to long-term care facilities—have recognized VENDAJE as a vital tool in their efforts to treat pressure ulcers. Each of these posts emphasizes VENDAJE’s role in supporting the treatment of specific types of wounds, highlighting its benefits and encouraging healthcare professionals to consider its use in their practice. If you need further customization or additional content, feel free to let me know! #BSEM #pressureulcer #woundcare #biostem #VANDAJE #BIORETAIN

16

ProScan utilizes state-of-the-art AI algorithms to accelerate and refine diagnostic accuracy in small bowel capsule endoscopy, ensuring rapid and precise patient evaluations. With FDA clearance and innovative features, ProScan supports clinicians in making informed decisions swiftly, enhancing both patient outcomes and clinical efficiency. Discover how ProScan can transform your practice. #anxrobotica #anxrobotics #fdaclearance #proscan #aiinhealthcare

20

‏1‏ ‏תגובה‏

#CustomerSuccess #CaseStudy When Israel-based CME (Caesarea Medical Electronics Ltd.), a global infusion pump systems manufacturer, was acquired by global medical technology giant BD (Becton, Dickinson and Company) (NYSE: BDX) in 2017, there were significant regulatory, quality management, validation and engineering gaps that needed to be closed. R.S NESS Group worked closely with BD and its Caesarea-based plant to close those gaps. What we found was: This set off a virtuous cycle 😇 that led not just to better processes but also to improved ROI as unit costs dropped and the profit margin grew! 🌟Product quality and consistency improved 🌟It became easier to pass audits - to the point of getting no findings from an MDSAP audit, which satisfies the regulatory requirements of 5 countries! 🌟Production capacity grew 🌟Profitability rose 30% in 2 years “We were looking not only for a consultancy that could lead the way in facilitating compliance with global regulatory and quality standards, but also for a partner that could become an integral, embedded part of the factory to fully actualize the plan – and we found that in R.S NESS,” said Idan Laifer , the BD plant manager responsible for the Casearea facility. It’s been a pleasure working hand in hand with BD and seeing the massive impact we were able to make together! 👇Follow the link in comments to read the case study. #regulatoryaffairs #qualitycontrol #RA #QA #partnership #growth #regulatorystrategy Rafi Shavit Zohar Zehavi Rafi Montias Kevin Greenstein Gabriel (Gabi) Salmon Nino Mamistvalov

27

‏5‏ ‏תגובות‏